Avaleht › Müeloom › Florida › Jacksonville
Müeloom kliinilised uuringud linnas Jacksonville, FL
18 uuringut haiguse Müeloom jaoks otsivad osalejaid linnas Jacksonville ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Värbamine
- Mayo Clinic in Florida, Jacksonville
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
VärbamineFaas 2
- Mayo Clinic in Florida, Jacksonville
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 3
- Mayo Clinic Jacksonville, Jacksonville
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 3
- Mayo Clinic Jacksonville, Jacksonville
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
VärbamineFaas 1
- Cancer Specialists of North Florida, Jacksonville
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
VärbamineFaas 1
- Mayo Clinic in Florida, Jacksonville
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
VärbamineFaas 3
- Mayo Clinic - Jacksonville, Jacksonville
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
VärbamineFaas 3
- Baptist MD Anderson Cancer Center, Jacksonville
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 2
- Mayo Clinic in Florida, Jacksonville
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 1
- Mayo Clinic Florida, Jacksonville
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
VärbamineFaas 1
- Mayo Clinic Hospital - Florida, Jacksonville
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
VärbamineFaas 1/2
- Research Site, Jacksonville
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
VärbamineFaas 2
- Mayo Clinic - Florida, Jacksonville
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
VärbamineFaas 1
- Mayo Clinic in Florida, Jacksonville
Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma
VärbamineFaas 2
- Mayo Clinic in Florida, Jacksonville
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
VärbamineFaas 3
- Mayo Clinic in Florida, Jacksonville
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
VärbamineFaas 2
- Mayo Clinic in Florida, Jacksonville
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
VärbamineFaas 1
- Cancer Specialists, LLC, Jacksonville
Müeloom uuringud teistes linnades
- New York City, NY60 uuringut
- Boston, MA42 uuringut
- Atlanta, GA41 uuringut
- Houston, TX38 uuringut
- Durham, NC37 uuringut
- Nashville, TN32 uuringut
- Denver, CO27 uuringut
- Rochester, MN24 uuringut
- St. Louis, MO24 uuringut
- Columbus, OH24 uuringut
- Baldwin Park, CA23 uuringut
- Chicago, IL22 uuringut
Muud uuringud linnas Jacksonville
- Rinnavähk40 uuringut
- Mitteväikerakuline kopsuvähk39 uuringut
- Vähk (kõik liigid)29 uuringut
- Metastaatiline vähk28 uuringut
- Käär- ja pärasoolevähk27 uuringut
- Eesnäärmevähk26 uuringut
- Rasvumine25 uuringut
- Südamepuudulikkus21 uuringut
- Pankreasevähk20 uuringut
- Ülekaalulisus19 uuringut
- Kopsuvähk17 uuringut
- Insult16 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.